The World Health Organization (WHO) on Friday recommended the use of two new drugs for the treatment of Covid-19 patients as the fast-spreading Omicron variant renders concerns. The UN body has recommended the two new drugs to treat patients showing critical symptoms, as well as for the non-severe cases. The WHO has recommended Eli Lilly & Co.’s rheumatoid arthritis drug and GlaxoSmithKline Plc’s monoclonal antibody. Lilly's baricitinib drug is a Janus kinase (JAK) inhibitor- a class of drugs used to treat autoimmune conditions, blood and bone marrow cancers, and rheumatoid arthritis.
As per the WHO, baricitinib is “strongly recommended" for patients with severe or critical disease in combination with corticosteroids. Whereas sotrovimab can be used for patients with non-severe cases.
Here's what the WHO said about the new anti-Covid drugs:
Never miss a story! Stay connected and informed with Mint. Download our App Now!!
Log in to our website to save your bookmarks. It'll just take a moment.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.
Your session has expired, please login again.
You are now subscribed to our newsletters. In case you can’t find any email from our side, please check the spam folder.
This is a subscriber only feature Subscribe Now to get daily updates on WhatsApp